Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Found vs Trillium Meds

Found
Graded #14

Higher grade

vs+14.299999999999997
Trillium Meds
Graded #136

Lower grade

The verdict

Found takes it — 83.5/100 to 69.2/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The broadest medication bench on the board — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFound +9
78
69
Dose & formulationFound +30
94
64
Clinical oversightFound +2
86
84
Labs & monitoringFound +7
82
75
FulfillmentFound +5
84
79
Contract termsFound +50
70
20
Found · left barTrillium Meds · right bar

The numbers

MetricFoundTrillium Meds
WeighScore83.5/10069.2/100
GradeBC
Scorecard rank#14#136
SemaglutideCompounded from $99/mo$119/mo (3-month plan, compounded)
TirzepatideCompounded from $99/mo$199/mo (3-month plan, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Found

Graded #14 · B

Strengths

  • Widest medication list on this board — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
  • Flat pricing as the dose increases, so a titration does not raise the monthly cost
  • Bills insurance for the clinical visits — the site states most members pay under $30 per visit
  • Runs a dedicated GLP-1 microdose programme for people who want a lower starting dose

Where it loses points

  • The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
  • Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
  • The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
  • Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
Trillium Meds

Graded #136 · C

Strengths

  • LegitScript certified with an active seal; serves all 50 states plus Puerto Rico with no geographic restrictions
  • All-inclusive pricing covers medication, provider consultation, and shipping with no hidden fees or add-ons
  • Two pharmacy options (BPI Labs with B6, ProRx) and three plan structures: 1-month, 3-month fixed, or 3-month titrated
  • Small owner-operated; founder personally handles customer support outside business hours for direct, responsive service
  • Klarna and Affirm financing available; pause anytime with no long-term commitment required

Where it loses points

  • No labs, coaching, or clinical monitoring included — telehealth Rx and pharmacy fulfillment only
  • Small single-operator platform may limit capacity and support consistency as patient volume grows
  • Compounded medications are not FDA-approved; newer platform with limited long-term public track record
  • Tirzepatide from $199/mo (3-mo plan) is mid-market; sema from $119/mo competitive but not lowest available
  • No live video consult disclosed; async intake-form-based provider review by external licensed provider network

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard